Publications 2025

Gundersen ET, Wang Z, Førde JL, Larquet E, Æsøy R, Roussel H, Tosi L, Barratt G, Herfindal L, Legrand FX (2025)
Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform
Carbohydr Polym, 358, 123478
DOI 10.1016/j.carbpol.2025.123478, PubMed 40383608

Publications 2024

Førde JL, Alhourani A, Carey T, Arbab A, Fladmark KE, Skrede S, Mollnes TE, Herfindal L, Hagland HR (2024)
Impact of the Graphene Production Methods Sonication and Microfluidization on In Vitro and In Vivo Toxicity, Macrophage Response, and Complement Activation
ACS Omega, 9 (39), 40468-40476
DOI 10.1021/acsomega.4c03189, PubMed 39372034

Hemsing AL, Førde JL, Reikvam H, Herfindal L (2024)
The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae
Transl Oncol, 40, 101876
DOI 10.1016/j.tranon.2024.101876, PubMed 38185059

Reiten IN, Giraud F, Augedal TT, Førde JL, Moreau P, Gundersen ET, Chapron D, Legrand FX, Anizon F, Herfindal L (2024)
Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cells
Int J Pharm, 668, 124989
DOI 10.1016/j.ijpharm.2024.124989, PubMed 39581514

Publications 2023

Augis L, Nerbø Reiten I, Førde JL, Casas-Solvas JM, Sizun C, Bizien T, Rajkovic I, Larquet E, Michelet A, Collot M, Lesieur S, Herfindal L, Legrand FX (2023)
Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substances
Int J Pharm, 651, 123723
DOI 10.1016/j.ijpharm.2023.123723, PubMed 38110013

Førde JL, Herfindal L, Myhr KM, Torkildsen Ø, Mollnes TE, Skrede S (2023)
Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro
Int Immunopharmacol, 124 (Pt B), 111021
DOI 10.1016/j.intimp.2023.111021, PubMed 37816262

Publications 2022

Alhourani A, Førde JL, Nasrollahzadeh M, Eichacker LA, Herfindal L, Hagland HR (2022)
Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish
Nanoscale Adv, 4 (6), 1668-1680
DOI 10.1039/d1na00778e, PubMed 36134366

Førde JL, Reiten IN, Fladmark KE, Kittang AO, Herfindal L (2022)
A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae
Biol Open, 11 (12)
DOI 10.1242/bio.059530, PubMed 36355409

Publications 2021

Alhourani A, Førde JL, Eichacker LA, Herfindal L, Hagland HR (2021)
Improved pH-Responsive Release of Phenformin from Low-Defect Graphene Compared to Graphene Oxide
ACS Omega, 6 (38), 24619-24629
DOI 10.1021/acsomega.1c03283, PubMed 34604644

Gundersen ET, Førde JL, Tislevoll BS, Leitch C, Barratt G, Gjertsen BT, Herfindal L (2021)
Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation
Int J Pharm, 612, 121296
DOI 10.1016/j.ijpharm.2021.121296, PubMed 34793932